FACTOR CERTIFICATE SHORT - NOVARTIS N Share Price

Certificat

S5NOVU

CH1107064599

Market Closed - Swiss Exchange 16:20:00 16/05/2024 BST
0.28 CHF +3.70% Intraday chart for FACTOR CERTIFICATE SHORT - NOVARTIS N
Current month-20.00%
1 month-37.78%
Date Price Change
16/05/24 0.28 +3.70%
14/05/24 0.27 -3.57%
13/05/24 0.28 -3.45%
10/05/24 0.29 -9.38%

Delayed Quote Swiss Exchange

Last update May 16, 2024 at 04:20 pm

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying NOVARTIS AG
Issuer UBS
S5NOVU
ISINCH1107064599
Date issued 30/07/2021
Strike 118.9 CHF
Maturity Unlimited
Parity 70.44 : 1
Emission price 4.92 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 6.01 CHF
Lowest since issue 0.27 CHF
Spread 0.01 CHF
Spread %3.57%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
102.9 USD
Average target price
107.9 USD
Spread / Average Target
+4.91%
Consensus
  1. Stock Market
  2. Certificates
  3. S5NOVU Certificat